MedTrace Logo

Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment

NCT07041359 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-09-29

No results posted yet for this study

Summary

To explore the effectiveness of compound Danshen Dripping Pill and Qishen Yiqi Dripping Pill in the elderly population with coronary heart disease and the safety of multiple medications

Conditions

  • Coronary Arterial Disease (CAD)

Interventions

DRUG

Compound Danshen Dripping Pills

The experimental group used compound Danshen dripping pills as an intervention on the basis of conventional western medicine treatment.

DRUG

Qishen Yiqi Drop Pills

The experimental group used Qishen Yiqi dripping pills as an intervention on the basis of conventional western medicine treatment.

DRUG

Placebo

Intervention with placebo on the Basis of optimal medical treatment

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-18
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07041359 on ClinicalTrials.gov